Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study

BACKGROUND: Optimal timing of implantation of an implantable cardioverter/defibrillator (ICD) after newly diagnosed heart failure is unclear given that late reverse remodelling may occur. We aimed to analyze left ventricular ejection fraction (LVEF) after diagnosis of an LVEF ≤35% during optimizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncker, David, König, Thorben, Hohmann, Stephan, Bauersachs, Johann, Veltmann, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523634/
https://www.ncbi.nlm.nih.gov/pubmed/28096098
http://dx.doi.org/10.1161/JAHA.116.004512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523634/
https://www.ncbi.nlm.nih.gov/pubmed/28096098
http://dx.doi.org/10.1161/JAHA.116.004512

Ejemplares similares